Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
21491979	s-prlbio	mu/l (mu/l)	1646	2327	0.00%
21491979	s-prlbio	— (—)	108	114	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Exclusions for E4_PCOS_CONSORTIUM

721

686

6.68

307.65

1.7

1.2

996.96

384.41

mu/l

3.23

687

647

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

479

317

15.56

307.65

1.8

1.4

1107.28

421.84

mu/l

2.13

465

296

Disorders of other endocrine glands

691

493

14.20

307.65

1.8

1.2

1066.91

384.59

mu/l

3.62

668

464

Exclusions for E4_PCOS_BROAD

652

152

46.85

307.65

1.8

1.2

1120.92

363.61

mu/l

3.85

628

144

Endocrine, nutritional and metabolic diseases

538

595

4.63

174.47

1.6

1.1

598.06

374.32

mu/l

2.93

517

559

Female infertility

301

315

5.99

137.58

1.3

1.5

349.09

782.95

mu/l

5.01

290

299

Kela-code for severe mental illness

279

576

4.90

125.85

1.5

1.4

807.89

479.04

mu/l

2.79

257

549

Schizophrenia or delusion, excluding more controls

233

415

5.64

122.71

1.5

822.10

493.48

mu/l

2.99

214

403

Anxiety (asthma-related co-morbidities)

399

839

3.78

119.82

1.4

1.5

622.61

470.23

mu/l

1.34

375

808

Unspecified mental disorder

296

682

4.39

116.55

1.4

802.02

468.04

mu/l

3.30

272

653

Depression

501

1080

3.21

113.41

1.4

593.13

712.80

mu/l

0.46

470

1036

Female infertility, cervigal, vaginal, other or unspecified origin

248

299

5.63

111.21

1.3

1.5

310.68

801.40

mu/l

5.70

237

283

Mood disorders

516

1090

3.13

110.23

1.4

576.47

711.27

mu/l

0.55

483

1045

Mood [affective] disorders

515

1091

3.12

109.81

1.4

577.21

710.80

mu/l

0.54

482

1046

Used for control exclusion in common control thyroid runs

520

853

3.10

100.56

1.6

1.2

962.60

498.79

mu/l

1.27

494

808

Mood disorders, excluding more controls

445

827

3.29

100.56

1.4

1.5

548.34

769.94

mu/l

0.81

414

794

All anxiety disorders

413

1026

3.27

100.47

1.4

628.67

486.35

mu/l

1.34

388

979

Schizophrenia or delusion

233

509

4.63

98.28

1.5

822.10

452.26

mu/l

5.11

214

488

Schizophrenia, schizotypal and delusional disorders

233

510

4.62

98.05

1.5

822.10

451.56

mu/l

5.13

214

489

Other and unspecified nonorganic psychotic disorders

190

358

5.40

95.46

1.5

1.4

834.06

391.24

mu/l

9.06

172

342

Anxiety disorders, excluding more controls

396

810

3.26

90.78

1.4

1.5

557.52

776.18

mu/l

0.76

372

778

Neurotic, stress-related and somatoform disorders

454

1123

2.89

87.12

1.4

601.98

677.32

mu/l

0.27

426

1071

Anxiety disorders

455

1124

2.88

86.97

1.4

601.98

706.32

mu/l

0.39

426

1073

Irregular menses

330

828

3.26

80.39

1.5

1.4

507.76

563.84

mu/l

0.54

311

787

Hypothyroidism (congenital or acquired)

240

319

4.37

77.17

1.5

1.4

568.12

518.06

mu/l

0.15

225

305

Hypothyroidism, levothyroxine purchases

238

318

4.35

76.21

1.5

1.4

573.69

519.29

mu/l

0.16

223

304

Hypothyroidism and >3 levothyroxin purchases

238

318

4.35

76.21

1.5

1.4

573.69

519.29

mu/l

0.16

223

304

Other anxiety disorders

312

918

3.04

69.33

1.3

1.4

667.75

484.33

mu/l

1.41

293

876

Personality disorders, excluding more controls

190

467

4.11

68.99

1.4

1.5

625.62

503.20

mu/l

0.46

176

450

Schizophrenia

114

182

6.34

68.14

1.5

892.28

365.06

mu/l

6.42

102

177

Polycystic ovarian syndrome, consortium definition

394

860

2.78

67.34

1.5

1.4

478.39

568.29

mu/l

1.18

375

819

Hypothyreosis and Thyroxine purchase for inclusion criteria

409

1044

2.60

63.27

1.6

1.4

639.46

686.70

mu/l

0.12

383

997

Disorders of the thyroid gland

420

1076

2.56

63.09

1.5

1.4

668.32

664.63

mu/l

0.01

392

1030

Hypothyroidism, other/unspecified

400

1013

2.62

62.88

1.5

1.4

635.48

676.02

mu/l

0.10

374

969

Disorders of adult personality and behaviour

208

650

3.23

52.92

1.4

1.5

612.62

485.61

mu/l

0.63

192

624

Noninflammatory disorders of female genital tract

260

412

3.20

52.73

1.4

1.5

372.93

710.19

mu/l

4.80

245

391

Acute and transient psychotic disorders

132

6.53

52.28

1.4

1.5

936.78

382.11

mu/l

4.52

127

Medical observation and evaluation for suspected diseases and conditions

296

525

2.90

51.83

1.4

475.64

856.55

mu/l

1.04

276

503

Bipolar affective disorders

139

338

4.16

51.37

1.4

619.88

460.40

mu/l

0.95

128

327

Recurrent or chronic depression

207

457

3.29

49.85

1.3

1.5

511.88

535.16

mu/l

0.07

199

441

Personality disorders

190

593

3.24

48.49

1.4

625.62

491.85

mu/l

0.60

176

572

Psychiatric diseases

386

822

2.36

45.43

1.4

1.5

503.65

769.63

mu/l

1.04

364

790

Benign neoplasms

426

1080

2.21

44.70

1.6

1.3

1106.70

461.78

mu/l

1.65

415

1012

Any mental disorder

386

832

2.33

44.26

1.4

1.5

512.77

766.74

mu/l

0.99

364

799

Specific personality disorders

165

509

3.27

43.00

1.4

1.5

504.48

473.35

mu/l

0.22

152

489

Other antidepressants

386

886

2.28

42.75

1.4

496.95

757.59

mu/l

1.13

363

844

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

166

518

3.23

42.40

1.4

1.5

675.34

427.74

mu/l

2.72

152

500

Benzodiazepine use

367

1201

2.18

39.82

1.3

1.4

635.07

698.81

mu/l

0.21

343

1147

Headache

287

1015

2.37

39.28

1.4

547.54

707.82

mu/l

0.60

274

967

Benign neoplasms

386

1008

2.17

39.22

1.6

1.3

660.12

469.13

mu/l

1.40

378

945

Examination and observation for other reasons

230

522

2.69

37.48

1.4

524.32

859.81

mu/l

0.79

220

500

Hirsutism in women

10.54

36.56

1.2

1.5

400.15

438.17

mu/l

0.16

Selective serotonin reuptake inhibitors

368

897

2.17

36.37

1.5

1.4

520.97

751.70

mu/l

0.87

350

855

Substance abuse, excluding more controls

190

618

2.70

34.47

1.3

1.5

581.85

865.86

mu/l

0.75

175

592

Migraine

258

960

2.30

33.01

1.4

509.00

523.82

mu/l

0.10

250

910

Hypertrichosis

8.79

32.86

1.2

1.5

394.02

427.68

mu/l

0.15

Mixed and other personality disorders

120

5.42

32.57

1.3

1.5

949.81

435.34

mu/l

0.94

114

Poisoning by medicine

135

441

3.09

32.11

1.3

1.4

694.51

417.33

mu/l

3.28

126

422

Other disorders of fluid, electrolyte and acid-base balance

158

4.60

31.51

1.2

1.4

494.40

1034.52

mu/l

0.42

151

Emotionally unstable personality disorder

111

330

3.41

30.91

1.3

1.4

536.68

442.35

mu/l

0.91

101

313

Other nutritional deficiencies

260

1164

2.19

30.62

1.5

1.4

443.37

701.20

mu/l

1.69

248

1107

Episodal and paroxysmal disorders

420

1122

1.92

30.24

1.5

1.4

507.62

647.95

mu/l

0.76

401

1060

Poisoning by drugs, medicaments and biological substances

138

479

2.90

29.52

1.3

1.5

687.59

452.90

mu/l

2.15

128

460

General examination and investigation of persons without complaint and reported diagnosis

233

525

2.37

28.51

1.4

543.07

856.55

mu/l

0.78

224

503

Obesity

244

1123

2.16

27.85

1.5

1.4

434.11

708.51

mu/l

1.77

232

1071

Ovarian dysfunction

184

4.15

27.68

1.3

1.2

389.59

408.04

mu/l

0.11

171

Obesity and other hyperalimentation

244

1125

2.15

27.67

1.5

1.4

434.11

708.13

mu/l

1.77

232

1073

Depression or dysthymia

222

526

2.37

27.57

1.4

1.5

418.00

926.36

mu/l

1.49

213

507

Depression medications

180

342

2.66

27.23

1.4

466.85

506.62

mu/l

0.23

168

328

Neoplasms

363

1008

1.94

27.03

1.6

1.3

655.59

468.40

mu/l

1.25

355

944

Genitourinary diseases

221

468

2.37

26.71

1.4

1.5

347.12

1050.38

mu/l

2.10

208

447

Symptoms and signs involving cognition, perception, emotional state and behaviour

302

1064

1.99

26.12

1.3

1.5

587.45

751.04

mu/l

0.50

291

1008

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

166

676

2.47

25.95

1.4

1.5

675.34

480.34

mu/l

1.94

152

647

Malaise and fatigue

151

480

2.63

25.90

1.4

1.5

457.28

838.74

mu/l

0.93

144

458

Other symptoms and signs involving cognitive functions and awareness

102

300

3.20

25.61

1.3

1.5

380.02

686.64

mu/l

0.85

286

Hypothyroidism, strict autoimmune

237

724

2.17

25.34

1.4

1.3

480.92

471.16

mu/l

0.06

215

688

Substance use, excluding alcohol

306

3.23

25.24

1.3

1.5

601.29

422.30

mu/l

1.57

291

Excessive, frequent and irregular menstruation

172

379

2.54

24.59

1.4

1.5

460.28

741.18

mu/l

2.44

160

358

Mental and behavioural disorders due to sedatives or hypnotics

5.35

24.20

1.3

1.4

551.56

408.55

mu/l

0.69

Suicide or other Intentional self-harm

123

453

2.73

23.65

1.3

1.5

746.50

425.59

mu/l

3.41

113

433

Other and unspecified mood [affective] disorders

147

4.21

23.08

1.4

1.5

835.76

384.58

mu/l

2.15

139

Metabolic disorders

251

774

2.02

21.97

1.4

1.5

577.52

750.53

mu/l

0.47

237

740

Sleep disorders (combined)

291

1002

1.91

21.96

1.5

1.4

701.12

719.88

mu/l

0.03

278

951

Visual disturbances and blindness

157

683

2.31

21.23

1.4

650.80

720.69

mu/l

0.13

150

654

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

100

354

2.85

20.81

1.3

1.4

738.11

421.09

mu/l

3.73

338

General symptoms and signs

376

1071

1.76

20.79

1.4

478.48

715.30

mu/l

1.30

357

1020

Polycystic ovarian syndrome

155

3.95

20.75

1.4

1.2

335.02

420.30

mu/l

0.99

144

Substance abuse

190

860

2.12

20.68

1.3

1.5

581.85

754.88

mu/l

0.56

175

818

Persons encountering health services for other counselling and medical advice, not elsewhere classified

354

1144

1.77

20.41

1.4

667.67

692.91

mu/l

0.06

335

1086

Post-traumatic stress disorder

209

3.44

20.25

1.3

1.4

508.09

510.82

mu/l

0.01

197

Mental and behavioural disorders due to psychoactive substance use

195

887

2.08

20.23

1.3

1.4

574.48

750.93

mu/l

0.60

180

843

Phobic anxiety disorders

324

2.90

19.94

1.3

1.4

560.24

472.37

mu/l

0.49

312

Neurological diseases

335

941

1.80

19.77

1.5

1.4

466.88

657.85

mu/l

0.99

321

894

Special screening examination for infectious and parasitic diseases

139

435

2.40

19.35

1.5

1.4

552.20

512.92

mu/l

0.09

126

416

Sleep apnoea

216

731

2.01

19.12

1.5

1.4

717.34

786.59

mu/l

0.09

207

692

Nonorganic sleeping disorders, excluding more controls

286

2.96

18.78

1.5

574.91

435.21

mu/l

0.63

279

Implicit Sepsis

180

672

2.09

18.21

1.3

1.5

520.67

734.51

mu/l

0.61

171

643

Dental caries 2

291

1293

1.77

18.17

1.4

602.06

688.15

mu/l

0.24

272

1233

Pain and other conditions associated with female genital organs and menstrual cycle

353

2.68

18.09

1.3

1.5

461.07

753.28

mu/l

2.28

332

Dental caries 2 and operation codes

286

1297

1.76

17.36

1.4

608.68

688.34

mu/l

0.22

268

1236

Pain, not elsewhere classified

373

2.61

17.25

1.4

1.5

786.25

434.67

mu/l

0.95

358

Persons encountering health services in other circumstances, wide

369

1148

1.67

17.17

1.4

611.80

691.74

mu/l

0.22

351

1090

Dental caries 2, only avohilmo

286

1299

1.74

16.83

1.4

591.16

692.01

mu/l

0.29

267

1239

Visual disturbances

141

649

2.18

16.77

1.4

657.19

727.91

mu/l

0.12

134

620

Behavioural syndromes associated with physiological disturbances and physical factors

164

803

2.05

16.61

1.4

576.44

480.87

mu/l

0.76

152

768

Sleep apnoea, including avohilmo

235

823

1.86

16.47

1.5

1.4

691.14

778.31

mu/l

0.12

226

782

Other special examinations and investigations of persons without complaint or reported diagnosis

205

526

1.98

16.23

1.5

1.4

459.78

855.22

mu/l

1.10

191

504

Use of hypnotics and sedatives

296

994

1.72

15.90

1.4

1.5

677.71

739.50

mu/l

0.15

279

947

Disorders of lipoprotein metabolism and other lipidaemias

143

410

2.20

15.75

1.4

1.6

859.29

941.43

mu/l

0.08

135

392

Disorders of skin appendages

182

954

1.91

15.20

1.3

1.5

503.40

521.66

mu/l

0.11

173

905

Other headache syndromes

140

670

2.10

15.13

1.4

1.5

461.61

551.42

mu/l

0.77

135

633

Condition for Implicit Sepsis (Organ dysfunction codes)

216

857

1.83

15.00

1.4

1.5

521.79

771.02

mu/l

0.94

204

816

Intestinal infectious diseases

300

1409

1.66

14.90

1.3

1.4

668.95

655.40

mu/l

0.03

283

1340

Anaemias

265

2.49

14.65

1.2

1.5

439.79

500.45

mu/l

0.32

253

Sleep disorders

396

2.41

14.36

1.5

1.4

558.32

458.01

mu/l

0.50

378

Alcohol dependence

251

2.80

14.33

1.2

1.5

504.98

1107.13

mu/l

0.73

240

Procreative management

146

611

2.02

13.94

1.4

1.5

403.18

551.92

mu/l

1.77

139

583

Obesity due to excess calories

160

830

1.93

13.86

1.4

460.51

736.12

mu/l

1.19

152

794

Insomnia

279

2.67

13.81

1.5

1.4

585.77

430.67

mu/l

0.78

264

Mental and behavioural disorders due to alcohol, excluding acute intoxication

122

577

2.12

13.61

1.2

1.5

572.09

875.72

mu/l

0.72

109

547

Pure hypercholesterolaemia

114

343

2.23

13.37

1.5

1.6

953.70

951.31

mu/l

0.00

109

331

Non-selective monoamine reuptake inhibitors

264

2.65

13.26

1.2

1.6

550.34

679.55

mu/l

0.22

251

Migraine, single triptan purchase ok & required. ICD-code if available is included

287

1194

1.63

13.04

1.4

524.47

534.51

mu/l

0.04

275

1135

Triptan medication for migraine, single purchase ok

287

1194

1.63

13.04

1.4

524.47

534.51

mu/l

0.04

275

1135

Alcohol use disorder, ICD-based

114

536

2.13

12.98

1.2

1.5

566.05

925.31

mu/l

0.83

102

509

Other diseases of hard tissues of teeth

190

784

1.81

12.81

1.4

473.20

567.04

mu/l

0.63

178

749

Alcohol use disorder, Swedish definition

148

711

1.94

12.78

1.3

1.5

604.11

776.70

mu/l

0.43

134

676

Mental and behavioural disorders due to alcohol

144

722

1.95

12.71

1.2

1.5

544.64

812.86

mu/l

0.82

131

688

Any reimbursement code in KELA

263

784

1.68

12.68

1.5

1.4

507.57

576.02

mu/l

0.32

250

750

Other disorders of lacrimal gland

362

2.36

12.30

1.4

1.5

393.76

441.73

mu/l

0.54

343

Tramadol

207

763

1.75

12.06

1.5

1.4

639.58

791.81

mu/l

0.35

199

728

Oedema, not elsewhere classified

274

2.55

12.00

1.3

1.5

525.82

515.54

mu/l

0.02

262

Nonorganic sleeping disorders

361

2.34

11.95

1.5

1.4

574.91

436.04

mu/l

0.79

344

167

825

1.82

11.81

1.3

1.4

584.94

758.42

mu/l

0.51

153

785

Convulsions, not elsewhere classified

393

2.24

11.51

1.3

1.5

491.35

492.42

mu/l

0.00

377

157

788

1.83

11.50

1.2

1.4

540.79

784.46

mu/l

0.80

144

750

Other/unspecified dorsalgia

106

512

2.07

11.16

1.4

1.5

518.27

485.84

mu/l

0.14

487

Symptoms and signs involving the circulatory and respiratory systems

351

1162

1.52

11.09

1.5

1.4

497.65

633.91

mu/l

1.05

330

1105

Cystitis

270

1037

1.59

11.08

1.4

587.26

668.60

mu/l

0.25

252

991

Pain in joint

172

637

1.79

11.01

1.6

1.4

512.49

728.36

mu/l

0.92

164

604

Disorders of lacrimal system

467

2.10

10.86

1.4

1.5

398.72

460.63

mu/l

0.77

443

Dermatitis and eczema

319

1377

1.52

10.82

1.5

1.4

545.23

690.44

mu/l

0.78

303

1307

Renal failure

241

2.51

10.82

1.3

882.92

1192.79

mu/l

0.22

229

Antihypertensive medication - note that there are other indications

291

1020

1.56

10.77

1.4

524.93

518.27

mu/l

0.04

278

968

Care involving use of rehabilitation procedures

154

813

1.80

10.76

1.4

1.5

543.23

826.38

mu/l

1.04

149

776

Diarrhoea and gastroenteritis of presumed infectious origin

223

1264

1.61

10.16

1.3

1.4

493.15

634.88

mu/l

0.78

210

1201

Hypothyroidism, strict autoimmune, 3 medication purchases required

233

995

1.60

9.97

1.4

479.53

696.48

mu/l

1.03

212

951

Hypertrophy of breast in women and men

266

2.42

9.88

1.4

1.5

461.16

428.57

mu/l

0.17

253

Heart failure, not strict

112

391

1.98

9.83

1.5

808.67

956.18

mu/l

0.14

106

375

Irritable bowel syndrome

439

2.08

9.82

1.5

488.96

499.68

mu/l

0.05

419

Social phobias

192

2.68

9.69

1.3

1.5

537.62

411.39

mu/l

0.77

183

Dentinal caries

305

2.29

9.61

1.5

1.4

514.06

422.52

mu/l

0.67

292

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

132

662

1.83

9.55

1.2

1.4

580.92

471.56

mu/l

1.05

123

627

Dorsalgia

320

1169

1.48

9.40

1.5

1.4

790.04

626.45

mu/l

0.22

307

1104

KRA_PSY_EATING, excluding more controls

269

2.36

9.16

1.2

1.5

535.63

446.37

mu/l

0.36

259

Dental caries

361

2.15

9.16

1.5

1.4

508.99

494.14

mu/l

0.06

343

Asthma-related infections

161

943

1.68

8.99

1.5

1.4

497.33

729.41

mu/l

1.05

153

893

Asthma, hospital admission 2, infections

161

943

1.68

8.99

1.5

1.4

497.33

729.41

mu/l

1.05

153

893

Diseases of male genital organs

110

282

1.98

8.97

1.3

1.4

415.84

1345.54

mu/l

1.41

100

268

Other functional intestinal disorders

107

540

1.89

8.81

1.2

1.5

678.68

531.97

mu/l

0.83

517

Triptan medication for migraine, min. 3 purchases

223

1133

1.56

8.78

1.4

623.25

524.37

mu/l

0.35

214

1079

Diaphragmatic hernia

226

2.44

8.74

1.4

1.5

464.76

510.42

mu/l

0.14

215

Neurological diseases, wide definition

151

431

1.76

8.72

1.4

436.89

633.36

mu/l

1.55

142

412

Gastroduodenal ulcer

119

3.02

8.62

1.4

1.5

592.55

612.74

mu/l

0.03

114

Low back pain

217

1076

1.56

8.51

1.5

1.4

1048.63

640.44

mu/l

0.41

208

1017

Dental caries 2 and operation codes, only avohilmo

237

958

1.54

8.50

1.4

617.41

669.42

mu/l

0.11

222

913

Complications of medical and surgical care

164

947

1.65

8.42

1.2

1.5

517.78

737.76

mu/l

0.88

153

905

140

813

1.71

8.37

1.6

1.4

486.18

548.33

mu/l

0.45

133

770

Hypertensive diseases (excluding secondary)

158

543

1.69

8.27

1.4

1.5

489.84

595.62

mu/l

0.63

153

517

Asthma (mode)

237

850

1.53

8.20

1.5

1.4

464.58

706.92

mu/l

1.65

227

813

Emotional disorders and disorders of social functioning with onset specific to childhood

183

2.56

8.19

1.2

1.4

599.86

409.41

mu/l

1.15

173

Fever of other and unknown origin

139

760

1.70

8.02

1.4

1.5

824.67

753.89

mu/l

0.09

131

724

Parasetamol

284

986

1.47

7.99

1.5

1.4

433.34

756.97

mu/l

1.86

272

936

Disorders of optic nerve and visual pathways

127

2.85

7.78

1.5

1150.57

400.42

mu/l

0.55

122

Lower back pain or/and sciatica

281

1350

1.45

7.67

1.5

1.4

927.37

618.12

mu/l

0.40

271

1277

Diseases of the skin and subcutaneous tissue

302

1051

1.44

7.66

1.4

536.10

613.37

mu/l

0.31

283

1003

Persons encountering health services for examination and investigation

171

526

1.63

7.57

1.4

471.68

855.22

mu/l

1.04

165

504

Exposure to unspecified factor

270

1452

1.44

7.49

1.3

1.4

546.54

681.11

mu/l

0.69

259

1377

Disorders of ocular muscles, binocular movement, accommodation and refraction

154

947

1.62

7.44

1.3

1.4

545.61

494.72

mu/l

0.35

143

904

Pain (limb, back, neck, head abdominally)

204

660

1.55

7.33

1.2

1.4

447.71

714.00

mu/l

1.46

192

625

Opioids

314

1165

1.42

7.32

1.4

462.62

690.78

mu/l

1.35

297

1107

Disorders of conjunctiva

244

1400

1.46

7.29

1.4

607.62

663.06

mu/l

0.21

235

1329

Endometriosis

298

1.88

7.04

1.3

1.5

358.17

805.69

mu/l

4.32

285

Conjunctivitis

229

1363

1.47

7.02

1.4

618.69

588.53

mu/l

0.12

221

1295

Abnormalities of breathing

277

1153

1.43

6.98

1.5

1.4

443.47

636.46

mu/l

1.96

264

1098

Mouth breathing

440

1.89

6.97

1.5

1.4

351.10

872.20

mu/l

1.26

418

Polyp of the female genital tract

169

2.17

6.91

1.3

1.5

435.18

765.53

mu/l

1.65

161

Certain disorders involving the immune mechanism

177

2.44

6.90

1.6

1.4

513.21

460.55

mu/l

0.22

171

Hypertension

180

655

1.56

6.80

1.4

1.5

474.92

570.51

mu/l

0.66

174

622

Constipation

174

804

1.55

6.79

1.3

1.5

756.76

748.99

mu/l

0.01

155

771

Ovarian cyst

104

335

1.80

6.77

1.4

1.5

452.86

769.04

mu/l

2.19

318

Complications of procedures, not elsewhere classified

189

1081

1.51

6.77

1.3

1.5

513.35

774.99

mu/l

1.31

177

1033

Asthma, excluding more controls

232

839

1.48

6.76

1.5

1.4

471.55

674.27

mu/l

1.35

223

803

Diseases of pulp and periapical tissues

460

1.85

6.74

1.5

688.16

656.36

mu/l

0.05

441

Hypertensive diseases

180

658

1.55

6.69

1.4

1.5

474.92

569.41

mu/l

0.65

174

624

Benign neoplasm of other and ill-defined parts of digestive system

2.94

6.68

1.2

1.5

555.90

439.27

mu/l

0.50

Asthma

232

847

1.47

6.67

1.5

1.4

471.55

708.21

mu/l

1.57

223

810

Other diseases of urinary system

284

1132

1.41

6.67

1.4

587.89

672.99

mu/l

0.28

266

1083

Symptoms and signs involving the urinary system

148

716

1.60

6.67

1.4

1.5

518.60

799.99

mu/l

0.90

136

686

Hypertension, essential

166

601

1.58

6.67

1.3

1.5

473.99

575.95

mu/l

0.63

159

570

Other soft tissue disorders, not elsewhere classified

278

1220

1.41

6.56

1.4

476.68

718.11

mu/l

1.52

265

1162

Codeine

284

1112

1.41

6.45

1.4

578.40

694.93

mu/l

0.39

266

1059

Hyperfunction of pituitary gland, other and/or unspecified

+∞

6.35

2.0

0.0

189.67

—

mu/l

—

Gastro-oesophageal reflux disease

134

740

1.61

6.30

1.3

1.5

1177.42

661.87

mu/l

0.32

129

708

Type 2 diabetes, wide definition

124

488

1.66

6.27

1.2

1.6

1455.10

771.21

mu/l

0.39

115

465

Atopic dermatitis

203

1184

1.47

6.24

1.4

488.93

526.41

mu/l

0.28

193

1122

Acute upper respiratory infections of multiple and unspecified sites

227

1186

1.44

6.17

1.4

467.34

587.82

mu/l

1.08

219

1122

Asthma, including avohilmo

327

1400

1.36

6.16

1.4

522.52

691.21

mu/l

0.99

315

1326

Symptoms and signs involving the skin and subcutaneous tissue

164

1078

1.52

6.11

1.4

543.58

719.53

mu/l

0.72

159

1022

Persons encountering health services in other circumstances

109

657

1.66

5.98

1.3

1.4

602.59

456.10

mu/l

1.00

103

623

Autoimmune diseases

330

1250

1.35

5.84

1.4

747.87

654.67

mu/l

0.12

313

1190

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

123

768

1.60

5.80

1.2

1.5

570.48

725.36

mu/l

0.41

116

730

Other and unspecified effects of external causes

551

1.71

5.77

1.4

599.80

486.42

mu/l

0.48

529

Other diseases of liver

143

2.45

5.76

1.2

1.4

346.05

442.64

mu/l

0.48

137

Transport accidents

148

859

1.53

5.69

1.3

1.5

1060.09

629.25

mu/l

0.29

139

819

Erosion of teeth, including avohilmo

364

1.86

5.69

1.2

1.3

410.43

516.24

mu/l

0.70

344

Diseases of the eye and adnexa

283

1030

1.38

5.69

1.5

1.4

598.48

671.86

mu/l

0.19

267

974

Other dorsopathies, not elsewhere classified

304

1182

1.36

5.66

1.5

1.4

775.64

623.79

mu/l

0.19

291

1117

Codeine or tramadol medication

307

1259

1.35

5.60

1.4

557.61

663.18

mu/l

0.39

288

1199

Diseases of liver

296

1.96

5.55

1.4

1.5

377.97

418.04

mu/l

0.23

283

Certain infectious and parasitic diseases

286

1047

1.37

5.55

1.4

468.47

687.83

mu/l

1.13

274

994

Use of pramipexole

122

2.55

5.52

1.7

1.4

707.06

431.91

mu/l

0.47

117

Asthma (only as main-diagnosis)

202

847

1.44

5.44

1.5

1.4

496.90

708.21

mu/l

1.28

192

810

Alcohol abuse, main dg, excluding more controls

166

2.30

5.42

1.3

1.6

469.70

366.02

mu/l

0.46

161

Cervical disc disorders

278

1.98

5.42

2.0

1.5

416.19

772.95

mu/l

0.86

264

Abdominal and pelvic pain

267

975

1.38

5.41

1.4

438.87

782.38

mu/l

1.95

248

934

Dorsopathies

314

1196

1.34

5.38

1.5

1.4

458.14

620.95

mu/l

1.50

301

1131

Type 2 diabetes

225

949

1.41

5.37

1.4

1.5

579.39

655.25

mu/l

0.25

210

906

Lumbar disc prolapse

136

702

1.54

5.35

1.5

702.45

688.90

mu/l

0.02

129

664

Asthma (only as main-diagnosis), excluding more controls

202

839

1.44

5.35

1.5

1.4

496.90

674.27

mu/l

1.07

192

803

Glomerular diseases

161

2.30

5.33

1.4

479.76

395.68

mu/l

0.51

155

Complications of surgical and medical care, not elsewhere classified

230

1186

1.39

5.29

1.3

1.4

533.58

741.84

mu/l

1.04

218

1131

Type 2 diabetes, definitions combined

196

813

1.44

5.28

1.3

1.5

1121.99

681.15

mu/l

0.39

180

776

Bronchitis

285

1390

1.35

5.25

1.4

471.62

707.84

mu/l

1.71

273

1319

Follicular cysts of skin and subcutaneous tissue

175

2.23

5.24

1.5

579.71

424.46

mu/l

0.35

167

Type 2 diabetes, strict (exclude DM1)

195

815

1.43

5.07

1.3

1.5

1127.07

681.90

mu/l

0.39

179

778

Strabismus

459

1.72

5.03

1.4

659.81

480.69

mu/l

1.00

441

Glucagon-like peptide-1 (GLP-1) analogues

274

1.86

4.97

1.2

1.5

776.47

1309.93

mu/l

0.47

262

Melanocytic naevi of trunk

148

2.31

4.92

1.6

1.5

2972.15

416.60

mu/l

0.46

141

Persons encountering health services for specific procedures and health care

287

1337

1.33

4.89

1.4

602.80

694.36

mu/l

0.33

276

1266

Type 2 diabetes, definitions combined, including avohilmo

198

829

1.41

4.88

1.3

1.5

613.15

688.58

mu/l

0.21

181

794

Injuries to the neck

420

1.74

4.86

1.3

1.4

486.91

479.72

mu/l

0.03

401

Other metabolic disorders

143

2.32

4.83

1.2

1.5

488.97

439.04

mu/l

0.17

138

Symptoms and signs involving the digestive system and abdomen

263

975

1.35

4.81

1.3

1.4

445.11

782.38

mu/l

1.89

243

934

Melanocytic naevi of trunk

150

2.28

4.78

1.6

1.5

2972.15

416.40

mu/l

0.46

145

Nutritional anaemias

505

1.66

4.78

1.3

1.5

1568.30

486.23

mu/l

0.47

479

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

111

714

1.56

4.76

1.2

1.5

517.62

748.49

mu/l

0.68

106

678

Diseases of oral cavity, salivary glands and jaws

216

799

1.39

4.66

1.5

1.4

423.95

562.37

mu/l

1.20

206

764

Acute upper respiratory infections

264

1239

1.34

4.65

1.4

1064.22

592.95

mu/l

0.58

254

1174

Eating disorder

353

1.79

4.61

1.2

1.4

535.63

516.01

mu/l

0.07

336

Cutaneous abscess, furuncle and carbuncle

390

1.75

4.60

1.4

475.65

411.58

mu/l

0.23

372

Inflammatory diseases of female pelvic organs

192

1038

1.40

4.59

1.4

470.69

551.87

mu/l

0.72

178

993

Dyspnoea

187

1023

1.40

4.59

1.6

1.4

481.84

743.51

mu/l

1.38

178

973

Haemorrhage, not elsewhere classified

8.23

4.56

1.4

1.5

584.33

369.45

mu/l

—

Eating disorders

371

1.76

4.48

1.2

1.4

526.76

500.31

mu/l

0.10

354

Pain in limb

208

1100

1.37

4.42

1.5

1.4

502.75

743.37

mu/l

1.27

198

1046

Pain in throat and chest

216

970

1.36

4.34

1.4

1060.82

679.21

mu/l

0.37

203

924

Iron deficiency anaemia

454

1.66

4.29

1.3

1.5

445.80

488.59

mu/l

0.28

428

Gingivitis and periodontal diseases

211

795

1.37

4.28

1.5

1.4

438.32

563.89

mu/l

1.02

200

760

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

120

394

1.53

4.27

1.3

1.4

432.12

876.69

mu/l

1.62

113

379

Disorders of breast

123

771

1.48

4.20

1.4

1.5

625.53

569.93

mu/l

0.13

118

736

Acute alcohol intoxication

298

1.82

4.18

1.3

1.5

471.43

664.79

mu/l

0.42

285

Asthma (diagnoses ohter than nonallergic)

221

1417

1.33

4.12

1.5

1.4

463.18

681.62

mu/l

1.59

211

1348

Infections with a predominantly sexual mode of transmission

120

813

1.48

4.11

1.3

1.5

396.35

554.29

mu/l

1.91

115

773

Diseases of the digestive system

494

1.62

4.11

1.6

1.4

583.47

788.64

mu/l

0.40

470

Other diseases of intestines

295

1330

1.29

4.07

1.3

1.4

492.60

710.19

mu/l

1.47

273

1273

Other disorders of skin and subcutaneous tissue

121

753

1.47

4.05

1.5

1298.87

609.22

mu/l

0.41

116

716

Injuries to the head

285

1439

1.29

4.03

1.3

1.4

546.57

681.87

mu/l

0.61

274

1364

Dental pulpitis 3

458

1.55

3.96

1.3

459.85

514.46

mu/l

0.36

437

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

216

1161

1.33

3.94

1.4

1142.41

633.28

mu/l

0.54

205

1103

L02BG Aromatase inhibitors

158

2.09

3.86

1.3

1.4

502.61

497.67

mu/l

0.01

150

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

158

1123

1.38

3.82

1.4

623.59

526.48

mu/l

0.56

151

1069

Other (not insulin) diabetes medications

192

854

1.36

3.80

1.4

1.5

564.59

801.40

mu/l

0.71

176

816

Disorders of eyelid, lacrimal system and orbit

165

939

1.38

3.79

1.6

1.4

495.62

730.76

mu/l

1.08

156

894

Concussion

127

764

1.44

3.78

1.3

1.4

1062.49

714.13

mu/l

0.32

120

724

Any gastric operation

263

1018

1.30

3.72

1.5

1.4

481.38

633.38

mu/l

1.15

252

970

GASTRO-related operations

263

1018

1.30

3.72

1.5

1.4

481.38

633.38

mu/l

1.15

252

970

Endometriosis diagnosis and infertility diagnosis occurring together

202

1.94

3.71

1.2

1.6

285.36

491.52

mu/l

4.09

193

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

113

759

1.46

3.67

1.4

1.5

1382.07

613.42

mu/l

0.43

108

720

Trigeminal neuralgia

3.12

3.65

1.4

1.6

557.43

482.36

mu/l

0.15

Diseases of inner ear

502

1.56

3.59

1.7

1.5

504.26

802.53

mu/l

0.65

478

Injuries to the abdomen, lower back, lumbar spine and pelvis

532

1.53

3.42

1.5

1.4

628.07

480.79

mu/l

0.58

512

First line medication for Crohn's disease

303

1317

1.26

3.40

1.5

1.4

497.05

702.32

mu/l

1.26

293

1245

Motor disorders, excluding more controls

5.11

3.38

1.4

1.6

651.33

292.25

mu/l

—

Exposure to other specified factors

193

1377

1.32

3.38

1.3

1.4

606.76

671.86

mu/l

0.24

182

1308

Excessive attrition of teeth

116

434

1.45

3.38

1.4

436.71

491.67

mu/l

0.38

110

413

Soft tissue disorders

303

1254

1.26

3.38

1.4

447.26

709.55

mu/l

1.81

287

1194

Biguanides

179

823

1.34

3.37

1.3

1.5

542.39

805.93

mu/l

0.77

164

786

Diabetes mellitus

244

1135

1.28

3.34

1.3

1.5

571.16

660.23

mu/l

0.35

230

1084

Other adrenocortical overactivity

8.77

3.28

2.3

1.0

478.83

284.57

mu/l

—

Cerebrovascular diseases

390

1.53

3.25

1.5

839.78

969.47

mu/l

0.10

373

Anosmia

8.51

3.24

1.0

3.1

295.67

971.86

mu/l

—

Diabetes, varying definitions

241

1127

1.28

3.21

1.3

1.5

573.92

660.27

mu/l

0.34

227

1076

Other intervertebral disc disorders

175

804

1.33

3.19

1.5

1.4

634.79

684.42

mu/l

0.09

166

763

Infections of the skin and subcutaneous tissue

142

1040

1.36

3.17

1.5

1.4

518.66

707.51

mu/l

0.74

133

988

Other strabismus

411

1.58

3.12

1.5

1.4

631.44

487.49

mu/l

0.62

393

Unspecified lump in breast

145

2.00

3.09

1.4

644.93

447.93

mu/l

0.39

139

Nerve, nerve root and plexus disorders

226

1110

1.28

3.08

1.6

1.4

838.14

692.52

mu/l

0.21

212

1060

Allergic conjunctivitis

161

1194

1.33

3.08

1.4

626.04

529.28

mu/l

0.57

154

1138

Desensitization to allergens

132

2.06

3.07

1.3

1.4

753.81

441.13

mu/l

0.85

126

Other factor of the environment

7.58

3.06

1.5

328.67

414.50

mu/l

—

Cardiovascular diseases (excluding rheumatic etc)

233

1057

1.27

3.03

1.4

481.85

556.29

mu/l

0.76

222

1006

Dental pulpitis 4

288

1203

1.24

3.01

1.4

438.18

579.40

mu/l

2.05

271

1147

Dental pulpitis 3, only avohilmo

436

1.48

3.00

1.3

468.91

522.38

mu/l

0.32

417

Congenital malformations, deformations and chromosomal abnormalities

183

1350

1.30

2.99

1.3

1.4

610.34

512.87

mu/l

0.35

176

1280

Diseases of pulp and periapical tissues, including avohilmo

287

1203

1.24

2.92

1.4

438.06

579.39

mu/l

2.05

270

1147

Other facial nerve disorders

4.73

2.92

1.4

1.8

1059.25

395.06

mu/l

—

Dental pulpitis 1

287

1204

1.24

2.91

1.4

439.10

579.06

mu/l

2.02

270

1148

Cardiovascular diseases

248

1076

1.26

2.87

1.4

450.77

552.54

mu/l

1.33

237

1027

Asthma, hospital admissions , main diagnosis only

206

1450

1.27

2.86

1.5

1.4

499.43

673.34

mu/l

1.12

196

1379

Specific development disorders of scholastic skills

122

2.04

2.79

1.5

1.3

627.28

374.26

mu/l

0.92

117

Diseases of oesophagus, stomach and duodenum

239

1159

1.25

2.77

1.3

1.5

937.03

665.29

mu/l

0.29

224

1103

Chronic diseases of tonsils and adenoids

223

1119

1.26

2.77

1.5

1.4

830.75

600.81

mu/l

0.37

211

1064

Alcohol abuse, main dg

217

1.76

2.75

1.3

1.4

469.70

411.83

mu/l

0.21

210

Intracranial trauma

142

796

1.33

2.74

1.3

1.4

999.13

706.43

mu/l

0.29

134

756

Sequelae of injuries, of poisoning and of other consequences of external causes

286

1.65

2.71

1.1

1.4

529.26

413.58

mu/l

0.32

277

Urticaria and erythema

677

1.41

2.64

1.5

1.4

823.08

503.34

mu/l

0.43

646

Injuries to the ankle and foot

199

1437

1.26

2.62

1.4

579.75

655.24

mu/l

0.30

189

1365

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

171

863

1.29

2.54

1.4

617.26

510.60

mu/l

0.41

163

823

Shoulder lesions

132

605

1.34

2.53

1.3

1.5

586.16

918.65

mu/l

0.86

127

577

Dental pulpitis 4, only avohilmo

285

1222

1.22

2.52

1.4

784.55

594.26

mu/l

0.24

269

1163

Acute alcohol intoxication, ICD10

270

1.63

2.48

1.3

1.4

534.84

408.06

mu/l

0.60

259

Other bacterial diseases

170

917

1.28

2.48

1.4

725.39

734.55

mu/l

0.01

161

874

Injuries to the thorax

504

1.45

2.43

1.3

1.4

1912.68

689.03

mu/l

0.42

478

Abnormal findings on antenatal screening of mother

361

0.50

2.38

1.4

1.5

242.83

514.37

mu/l

6.33

342

Spondylopathies

122

554

1.34

2.38

1.4

1.5

1385.78

742.85

mu/l

0.37

117

525

TMD muscular pain linked with fibromyalgia

6.32

2.38

1.0

2.0

253.20

621.63

mu/l

—

Bleeding

126

692

1.33

2.37

1.4

1.5

551.52

827.63

mu/l

0.80

120

659

Presence of other devices

125

1.92

2.34

1.2

1.4

472.63

411.15

mu/l

0.20

118

All influenza

314

1.56

2.34

1.4

489.80

820.84

mu/l

0.51

305

Puerperal sepsis

119

1.94

2.30

1.3

1.4

593.43

413.68

mu/l

0.80

113

Dental pulpitis 1, only avohilmo

283

1227

1.20

2.28

1.4

782.87

594.07

mu/l

0.23

267

1168

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

3.50

2.27

1.5

1.3

593.00

705.87

mu/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

154

985

1.28

2.26

1.6

1.4

464.74

548.13

mu/l

0.79

149

936

Supplementary factors related to causes of morbidity and mortality classified elsewhere

488

1.44

2.25

1.3

1.5

915.63

480.72

mu/l

0.77

470

Acute suppurative otitis media

113

800

1.32

2.18

1.3

1.4

718.98

510.54

mu/l

0.40

107

766

Intracranial injury

125

929

1.30

2.17

1.3

1.4

600.33

743.35

mu/l

0.31

117

875

Diseases of middle ear and mastoid

187

1235

1.24

2.17

1.3

1.4

624.13

490.21

mu/l

0.41

174

1173

Molar incisor enamel hypoplasia, with caries

4.34

2.15

1.2

384.50

380.00

mu/l

—

Other cataract

186

1.62

2.13

1.5

417.85

972.07

mu/l

0.54

177

Other obstetric conditions, not elsewhere classified

169

875

1.26

2.12

1.4

609.82

510.32

mu/l

0.37

161

835

Specific developmental disorder of motor function

2.97

2.10

1.4

1.2

651.33

378.71

mu/l

—

Acute sinusitis

140

1026

1.27

2.07

1.4

455.16

529.92

mu/l

0.72

133

972

Maternal care related to the fetus and amniotic cavity and possible delivery problems

110

846

0.76

2.04

1.3

1.5

548.76

533.88

mu/l

0.03

105

804

Diseases of external ear

416

1.44

2.02

1.3

1.4

474.65

435.15

mu/l

0.12

396

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

2.73

2.00

1.2

1.8

433.00

499.56

mu/l

—

Appendectomy

162

1255

1.24

1.99

1.4

454.17

688.85

mu/l

1.43

155

1190

False labour

761

0.75

1.97

1.2

1.4

657.89

527.04

mu/l

0.26

727

Other and unspecified trigeminal disorders

4.57

1.94

1.4

1.0

11766.60

365.45

mu/l

—

Disorders of gallbladder, biliary tract and pancreas

178

930

1.23

1.94

1.5

544.87

757.78

mu/l

0.84

166

885

Erosion and ectropion of cervix uteri

3.76

1.93

1.3

1.4

255.17

671.88

mu/l

—

Hyperhidrosis

2.46

1.93

1.1

1.6

278.55

449.64

mu/l

1.31

Diseases of the ear and mastoid process

307

1322

1.18

1.93

1.4

538.11

702.91

mu/l

0.66

289

1261

Other diseases of lip and oral mucosa

113

1.86

1.91

1.7

1.4

407.52

369.52

mu/l

0.22

106

Assault by bodily force

143

1.75

1.88

1.3

1.4

724.16

424.78

mu/l

0.59

137

Hypoplasia of dental enamel, including avohilmo

3.58

1.84

1.2

384.50

471.24

mu/l

—

Meralgia paraesthetica

3.54

1.84

1.0

1.5

606.00

479.82

mu/l

—

Other disorders of urethra and urinary system

151

912

1.24

1.80

1.5

1.4

570.40

699.96

mu/l

0.41

142

871

Provisional assignment of new diseases of uncertain etiology

118

928

1.27

1.80

1.3

1.5

560.00

523.85

mu/l

0.17

112

881

Codes for special purposes

118

928

1.27

1.80

1.3

1.5

560.00

523.85

mu/l

0.17

112

881

Motor disorders

2.51

1.73

1.4

1.1

651.33

375.73

mu/l

—

Renal tubulo-interstitial diseases

179

1133

1.21

1.72

1.4

551.52

705.26

mu/l

0.45

170

1076

Type 1 diabetes

439

1.39

1.71

1.4

1.5

451.36

491.89

mu/l

0.19

418

Other sexually transmitted chlamydial diseases

226

1.56

1.70

1.3

1.4

455.27

435.15

mu/l

0.08

211

Unspecified fall

711

1.30

1.68

1.2

1.4

890.25

578.25

mu/l

0.59

674

Other arthrosis

331

1.38

1.68

1.4

1.5

537.33

1149.26

mu/l

0.91

314

Maternal care for known or suspected abnormality of pelvic organs

624

0.74

1.66

1.3

1.5

321.75

531.54

mu/l

3.21

596

Diabetes medication

224

1149

1.19

1.65

1.3

1.5

536.73

751.53

mu/l

0.86

208

1098

Complications associated with artificial fertilization

2.82

1.65

1.0

1.4

249.14

666.84

mu/l

—

Unspecified privation

112

1.79

1.64

1.4

782.25

397.48

mu/l

1.34

107

Other acute lower respiratory infections

114

867

1.26

1.59

1.4

417.67

646.18

mu/l

1.14

107

824

Malignant neoplasm of skin

239

1.45

1.58

1.3

1.4

3560.20

673.15

mu/l

0.67

228

Other fall from one level to another

371

1.40

1.56

1.3

1.4

506.40

431.57

mu/l

0.38

353

Parodontitis and operation codes

140

887

1.23

1.56

1.5

528.67

784.54

mu/l

1.03

132

842

Diseases of the musculoskeletal system and connective tissue

188

787

1.20

1.55

1.4

420.50

667.26

mu/l

1.87

180

746

Urticaria

581

1.31

1.50

1.4

947.66

489.33

mu/l

0.52

555

Insulin, intermediate and long-acting

633

1.29

1.44

1.3

1.5

393.72

853.28

mu/l

1.61

604

Chronic lower respiratory diseases

300

1420

1.14

1.41

1.4

560.39

681.21

mu/l

0.61

286

1348

Inguinal hernia

532

0.75

1.41

1.6

1.4

389.60

932.56

mu/l

1.56

501

Suppurative and unspecified otitis media

133

970

1.22

1.41

1.2

1.4

664.36

502.77

mu/l

0.36

127

927

Falls/tendency to fall

297

1300

1.14

1.41

1.4

602.61

691.34

mu/l

0.30

283

1235

Other diseases of upper respiratory tract

255

1154

1.15

1.36

1.5

1.4

1029.94

593.97

mu/l

0.48

240

1099

Haemorrhoids and perianal venous thrombosis

199

1.51

1.34

1.2

1.4

457.40

569.20

mu/l

0.28

189

Abnormal findings in secretions and smears from cervix uteri vagina vulva

141

922

1.20

1.33

1.6

1.4

472.04

561.90

mu/l

0.80

136

875

Tonsillectomy and adenotomy

203

1213

1.17

1.33

1.4

1297.49

520.64

mu/l

0.77

193

1154

Gestational diabetes (for exclusion)

150

888

1.20

1.32

1.3

1.4

529.09

536.68

mu/l

0.02

144

846

Persons encountering health services in circumstances related to reproduction

145

819

1.20

1.32

1.2

1.4

434.41

544.65

mu/l

1.22

138

779

Sub-endpoint used in defining T1D endpoints

454

1.32

1.4

1.5

449.69

508.80

mu/l

0.30

434

Chronic rhinitis, nasopharyngitis and pharyngitis

488

1.31

1.32

1.7

1.4

400.93

495.20

mu/l

0.62

467

Chronic periodontitis, including avohilmo

147

909

1.20

1.31

1.5

514.97

775.13

mu/l

1.10

139

863

Diabetic retinopathy

241

0.65

1.29

1.6

1.3

487.00

987.00

mu/l

0.61

224

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

173

896

1.18

1.28

1.3

1.5

585.79

670.54

mu/l

0.25

162

856

Internal derangement of knee

559

1.29

1.28

1.3

1.4

400.82

861.86

mu/l

1.42

531

Parodontitis

147

909

1.19

1.27

1.5

514.26

775.15

mu/l

1.10

139

863

Dental caries 1 and operation codes

168

728

1.18

1.27

1.3

1.5

390.79

595.84

mu/l

2.17

160

697

Parodontitis or operation codes

147

909

1.19

1.26

1.5

514.26

775.15

mu/l

1.10

139

863

Type of accident

432

1.32

1.24

1.4

1000.58

459.26

mu/l

0.80

414

Dental caries 3 and operation codes

185

811

1.17

1.23

1.3

1.4

446.71

577.27

mu/l

1.14

176

774

Other congenital malformations of nervous system

2.65

1.22

1.2

1.4

683.00

468.27

mu/l

—

Ventral hernia

164

1.53

1.19

1.4

1.5

377.36

534.25

mu/l

0.54

157

Undetermined asthma

148

1.55

1.19

2.3

1.5

421.39

425.97

mu/l

0.02

143

Other enthesopathies

340

1.35

1.19

1.4

1.5

726.80

451.35

mu/l

0.70

327

Spondyloarthritis

222

1.44

1.18

1.3

1.5

446.00

423.72

mu/l

0.10

212

Gastrointestinal diseases

195

842

1.16

1.18

1.4

467.49

711.67

mu/l

1.66

189

806

Delayed milestone in childhood

2.08

1.16

1.6

1.1

474.88

454.43

mu/l

—

Nontoxic goitre/thyroid nodule

215

1.44

1.15

1.7

1.4

988.23

448.43

mu/l

0.44

208

Benign neoplasm of breast

118

1.61

1.14

1.3

873.32

477.42

mu/l

0.56

112

Asthma and allergy

364

1.33

1.14

1.3

1.4

601.24

522.84

mu/l

0.22

349

Paroxysmal tachycardia

246

1.38

1.12

1.6

425.25

409.61

mu/l

0.06

239

Other specific joint derangements/joint disorders

204

1192

1.15

1.12

1.5

1.4

472.17

728.56

mu/l

1.47

194

1130

Atypical facial pain

2.00

1.12

1.8

1.6

644.88

461.90

mu/l

—

Asthma and allergy, excluding more controls

366

1.32

1.11

1.3

1.4

601.24

526.65

mu/l

0.21

351

Undetermined asthma, excluding more controls

151

1.52

1.11

2.3

1.5

421.39

423.01

mu/l

0.01

145

Childhood allergy (age < 16)

612

1.23

1.10

1.4

487.10

488.99

mu/l

0.01

577

ILD medications: prednisolone, methylprednisolone, prednisone

259

1298

1.13

1.08

1.5

1.4

533.05

712.95

mu/l

0.95

251

1229

COPD differential diagnosis

195

850

1.15

1.06

1.4

457.67

706.92

mu/l

1.64

187

813

Other pulmonary diagnosis

196

855

1.15

1.06

1.4

457.30

707.28

mu/l

1.66

186

818

Anomalies of dental arch relationship, including avohilmo

422

1.28

1.05

1.3

1.4

614.74

503.63

mu/l

0.43

401

Benign neoplasm of ovary

113

1.59

1.05

1.3

1.5

501.92

466.15

mu/l

0.14

108

254

1191

1.13

1.04

1.4

1070.00

603.08

mu/l

0.54

243

1129

Other malignant neoplasms of skin (=non-melanoma skin cancer)

186

1.40

1.04

1.2

1.4

423.06

551.41

mu/l

0.46

176

L04AA Selective immunosuppressants

246

1.38

1.03

1.3

1.4

469.29

427.85

mu/l

0.21

236

Malignant neoplasm of prostate

136

0.60

1.00

1.2

1.4

371.69

1937.59

mu/l

1.12

128

Benign neoplasm of ovary

115

1.57

0.99

1.3

501.92

446.08

mu/l

0.24

110

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

493

1.21

0.99

1.4

1.5

504.20

547.88

mu/l

0.20

468

Diabetes, insulin treatment (Kela reimbursement)

174

928

1.15

0.97

1.3

1.5

584.51

776.26

mu/l

0.55

163

887

Inflammatory disorders of breast

132

1.52

0.97

1.4

1.5

670.25

440.62

mu/l

0.64

125

Pacemaker

136

1.50

0.97

1.6

1.4

382.62

573.81

mu/l

0.48

129

Multiple delivery

198

0.60

0.95

1.5

1.6

432.67

602.86

mu/l

0.49

183

Allergic asthma (mode)

576

1.23

0.94

1.4

1.5

541.29

560.30

mu/l

0.06

550

ILD differential diagnosis

193

850

1.14

0.94

1.4

453.22

706.92

mu/l

1.69

185

813

Maternal care for other known or suspected fetal problems

703

0.84

0.90

1.4

1.5

693.01

513.28

mu/l

0.37

671

Injuries to the hip and thigh

424

1.25

0.90

1.5

1.4

396.76

483.54

mu/l

0.56

403

Other arrhythmias

108

702

1.18

0.90

1.5

555.10

647.86

mu/l

0.28

103

665

Nonsuppurative otitis media

651

1.20

0.90

1.4

503.95

495.09

mu/l

0.03

620

Type 1 diabetes, wide definition, subgroup 1

375

1.28

0.90

1.4

1.5

452.06

513.73

mu/l

0.26

357

Allergic asthma (mode), excluding more controls

580

1.22

0.89

1.4

541.29

558.56

mu/l

0.06

554

Conductive and sensorineural hearing loss

565

1.19

0.89

1.3

1.5

383.84

873.78

mu/l

1.57

538

Suppurative otitis media, unspecified

1.91

0.88

1.1

1.2

463.63

321.16

mu/l

—

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

138

1.46

0.87

1.6

358.95

524.05

mu/l

1.30

133

Injuries to the elbow and forearm

143

1128

1.15

0.86

1.4

917.51

622.52

mu/l

0.65

130

1077

Diabetic retinopathy, excluding more controls

189

0.71

0.84

1.5

1.3

497.29

1152.22

mu/l

0.64

176

Abnormalities of forces of labour

203

0.64

0.84

1.3

1.6

503.69

459.85

mu/l

0.09

189

Cardiac arrhythmias

141

813

1.15

0.83

1.4

467.05

643.18

mu/l

0.88

135

777

Type 1 diabetes, strict definition, subgroup 1

202

0.64

0.83

1.2

1.4

365.75

414.92

mu/l

0.28

189

Systemic connective tissue disorders

389

1.26

0.83

1.3

1.5

410.01

433.80

mu/l

0.13

369

Juvenile arthritis (FINNGEN)

121

1.49

0.82

2.6

1.4

603.78

431.78

mu/l

0.67

114

Excluding asthma or asthma-COPD overlap

192

855

1.13

0.82

1.4

453.04

707.28

mu/l

1.70

184

818

Other joint disorders

254

1223

1.11

0.82

1.5

1.4

463.76

721.11

mu/l

1.63

242

1159

External causes of morbidity and mortality

176

780

1.13

0.82

1.3

1.5

494.29

564.91

mu/l

0.44

167

748

Other juvenile arthritis

105

1.53

0.81

2.4

1.3

645.25

447.20

mu/l

0.71

Open wound of ankle and foot

138

1.45

0.81

1.1

1.4

571.50

425.36

mu/l

0.56

132

Acute appendicitis, no complications

127

1105

1.15

0.80

1.4

461.00

713.09

mu/l

1.25

120

1050

Type 1 diabetes, wide definition

391

1.25

0.80

1.3

1.5

478.10

507.20

mu/l

0.11

373

Non-invasive ventilation

219

0.69

0.75

1.3

1.5

737.19

752.04

mu/l

0.02

213

Diseases of appendix

160

1298

1.12

0.75

1.4

464.62

727.68

mu/l

1.63

152

1230

Appendicitis, broad definition

159

1294

1.12

0.74

1.4

467.13

728.88

mu/l

1.61

151

1226

Type 1 diabetes, strict definition

207

0.67

0.73

1.2

1.4

463.06

431.58

mu/l

0.10

194

Palatinal maxillary operation

2.01

0.73

1.0

1.1

524.60

448.97

mu/l

—

malignant neoplasm of male genital organs

155

0.70

0.72

1.1

1.4

326.65

1747.34

mu/l

1.17

145

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

243

0.72

0.71

1.3

1.5

376.55

687.20

mu/l

1.13

231

Chondropathies

211

1.33

0.71

1.4

1.5

632.82

400.46

mu/l

0.87

203

Disorders of tooth development and eruption

122

1.44

0.71

1.2

1.4

479.28

423.70

mu/l

0.14

117

Arthropathies

263

1226

1.09

0.68

1.6

1.4

421.67

719.80

mu/l

2.18

257

1162

Other external causes of accidental injury

208

944

1.10

0.67

1.4

1.5

500.65

641.09

mu/l

0.85

199

900

Accidents

208

944

1.10

0.67

1.4

1.5

466.40

641.09

mu/l

1.27

199

900

Pedal cyclist injured in other and unspecified transport accidents

144

1.39

0.67

1.6

1.4

348.80

420.74

mu/l

0.71

138

Enlarged lymph nodes

179

1.34

0.66

1.2

1.6

316.42

411.11

mu/l

1.05

172

Pregnancy examination and test

433

1.17

0.65

1.4

455.90

550.78

mu/l

0.66

413

Postpartum haemorrhage due to anatomy

305

1.25

0.63

1.1

1.4

874.34

468.10

mu/l

0.39

292

Stomatitis and related lesions

104

1.44

0.62

1.6

1.4

445.80

422.99

mu/l

0.09

Other keratitis

138

1.38

0.62

1.1

1.5

619.75

409.10

mu/l

0.26

130

Dental operations, only avohilmo

105

471

1.14

0.62

1.4

1.5

369.30

666.61

mu/l

2.13

100

448

Injuries to the wrist and hand

224

1491

1.09

0.60

1.3

1.4

633.89

664.14

mu/l

0.08

217

1413

Insulin, combination of fast acting with intermediate-acting or long-acting

708

1.15

0.60

1.3

1.5

399.33

810.92

mu/l

1.60

674

ILD medications

271

1376

1.08

0.59

1.5

1.4

525.22

696.32

mu/l

0.96

261

1302

Acute appendicitis

149

1269

1.11

0.59

1.3

1.4

475.67

731.24

mu/l

1.48

142

1202

Finngen Rheumatological endpoints

203

1264

0.92

0.59

1.4

436.05

725.63

mu/l

2.05

196

1195

Embedded teeth, including avohilmo

290

1.24

0.59

1.2

1.4

513.89

465.47

mu/l

0.25

273

Basal cell carcinoma

195

1.27

0.58

1.2

1.5

425.00

1042.37

mu/l

0.64

185

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

114

0.61

0.57

1.3

1.4

365.43

646.78

mu/l

—

106

Tooth agenesis EXCLUDE clefts and syndromes

115

1.39

0.56

1.3

1.4

597.88

438.37

mu/l

0.42

110

Calcific aortic valvular stenosis

1.43

0.56

2.7

1.2

508.86

573.76

mu/l

0.09

Calcific aortic valvular stenosis, operated

1.43

0.56

2.7

1.2

508.86

573.76

mu/l

0.09

Operations 2 for CAVS

1.43

0.56

2.7

1.2

508.86

573.76

mu/l

0.09

Calcific aortic valvular stenosis, diagnosis (helper)

1.43

0.56

2.7

1.2

508.86

573.76

mu/l

0.09

Calcific aortic valvular stenosis, including rheumatic fever

1.43

0.55

2.7

1.2

508.86

573.76

mu/l

0.09

Other systemic involvement of connective tissue (FG)

273

1.24

0.55

1.3

1.5

396.14

437.35

mu/l

0.19

259

Coxibs

326

1.16

0.54

1.3

1.4

361.64

747.43

mu/l

2.59

306

Type1 diabetes, definitions combined, early onset

193

0.72

0.54

1.3

1.4

569.50

421.61

mu/l

0.57

183

Psoriasis vulgaris

186

1.29

0.54

1.4

372.94

444.94

mu/l

0.39

179

Spondylopathies (FG)

205

1.27

0.52

1.2

1.5

469.15

415.82

mu/l

0.22

195

Pruritus

117

1.37

0.52

1.3

1.4

286.06

391.95

mu/l

1.16

112

Basal cell carcinoma, including avohilmo

204

1.24

0.50

1.2

1.4

421.44

1165.82

mu/l

0.83

194

Other and unspecified tonsillitis

114

875

1.11

0.47

1.5

1.4

1068.05

551.53

mu/l

0.48

108

830

LSIL lesion of the cervix uteri

272

1.21

0.47

1.5

340.30

456.76

mu/l

1.11

258

Contact with and exposure to communicable diseases

1011

0.90

0.47

1.2

1.4

480.42

524.56

mu/l

0.21

966

LSIL lesion of the cervix uteri, vagina or vulva

318

1.20

0.47

1.5

321.41

454.12

mu/l

1.61

304

Diabetic nephropathy

153

1.29

0.46

1.2

1.3

420.15

1107.44

mu/l

0.54

144

Oral corticosteroids

225

1268

1.07

0.46

1.4

504.21

727.03

mu/l

1.26

220

1197

All influenza (not pneumonia)

209

1.24

0.46

1.2

1.4

553.65

517.48

mu/l

0.07

203

Insulin medication

672

1.12

0.46

1.3

1.5

399.33

846.47

mu/l

1.69

640

Placenta praevia

153

0.72

0.45

1.1

1.7

446.91

482.48

mu/l

0.08

145

Atherosclerosis, excluding cerebral and coronary sclerosis

149

0.75

0.44

1.0

1.4

438.86

1566.19

mu/l

0.83

141

Injuries to the knee and lower leg

268

1442

1.06

0.43

1.4

567.30

679.31

mu/l

0.44

256

1370

Respiratory insufficiency

1.61

0.43

2.0

1.6

522.40

338.52

mu/l

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

0.64

0.42

1.3

1.5

492.67

648.92

mu/l

—

Other systemic involvement of connective tissue

286

1.19

0.41

1.3

1.5

396.14

417.48

mu/l

0.09

269

Noninfective enteritis and colitis

805

1.10

0.39

1.3

1.4

456.57

581.01

mu/l

0.66

767

Childhood asthma (age<16)

458

1.13

0.39

1.3

1.4

561.83

516.66

mu/l

0.21

438

Childhood asthma (age<16), excluding more controls

458

1.13

0.39

1.3

1.4

561.83

516.66

mu/l

0.21

438

Acute and subacute iridocyclitis

205

1.22

0.39

1.2

1.4

540.87

414.00

mu/l

0.66

196

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

106

1.32

0.39

1.3

1.4

535.71

427.39

mu/l

0.21

100

Benign lipomatous neoplasm

251

1.20

0.39

1.9

1.5

505.97

525.64

mu/l

0.05

237

1.35

0.38

1.2

1.4

611.22

347.94

mu/l

—

Dislocation, sprain and strain of joints and ligaments of knee

135

1161

1.08

0.37

1.3

1.4

439.36

714.56

mu/l

1.70

125

1099

Psoriasis

310

1.16

0.35

1.4

372.79

413.47

mu/l

0.28

296

Colorectal cancer, excluding all cancers (controls excluding all cancers)

122

0.71

0.35

1.1

1.4

3749.11

676.74

mu/l

—

114

Presence of other functional implants

249

0.85

0.33

1.2

1.4

498.13

1289.94

mu/l

1.00

239

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

0.68

0.33

1.2

1.3

292.83

690.91

mu/l

—

Benign lipomatous neoplasm

256

1.17

0.33

1.9

1.4

505.97

412.09

mu/l

0.38

244

Chronic sinusitis

682

1.10

0.32

1.6

1.5

458.04

543.57

mu/l

0.57

651

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

100

0.78

0.32

1.2

1.4

376.08

941.20

mu/l

0.80

Medical abortion

145

843

0.93

0.32

1.4

433.39

547.07

mu/l

1.41

132

804

Anterior Iridocyclitis

220

1.18

0.31

1.2

1.4

529.84

413.97

mu/l

0.61

211

Other respiratory disorders and diseases

110

1.27

0.31

1.6

1.5

353.50

410.54

mu/l

0.21

105

Other diseases of the respiratory system

110

1.27

0.31

1.6

1.5

353.50

410.54

mu/l

0.21

105

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

171

1.17

0.30

1.2

1.5

443.00

839.84

mu/l

1.00

163

Acute appendicitis, with complications

187

1.18

0.26

1.1

1.5

555.68

415.57

mu/l

0.56

178

COPD/asthma related infections

231

1105

1.05

0.26

1.4

486.63

602.11

mu/l

0.95

218

1052

COPD/asthma/ILD related infections

231

1105

1.05

0.26

1.4

486.63

602.11

mu/l

0.95

218

1052

Congenital malformations of eye, ear, face and neck

141

1.21

0.26

1.4

735.29

384.81

mu/l

1.11

135

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

180

1.15

0.26

1.2

1.5

438.60

815.24

mu/l

1.00

172

Arthrosis

102

523

1.07

0.25

1.4

501.26

984.38

mu/l

1.21

495

Other obstetric trauma

138

0.80

0.25

1.3

1.6

441.55

464.51

mu/l

0.06

130

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

0.71

0.24

1.2

1.5

5378.17

719.91

mu/l

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

0.71

0.24

1.2

1.5

5492.33

719.92

mu/l

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

101

949

1.06

0.22

1.4

556.49

521.17

mu/l

0.13

904

Labour and delivery complicated by fetal stress [distress]

688

0.94

0.22

1.3

1.5

688.32

512.92

mu/l

0.41

654

Peripheral artery disease

176

1.14

0.22

1.0

1.4

463.20

1459.80

mu/l

0.88

166

Crohn disease (strict definition, require KELA, min 2 HDR)

104

0.77

0.21

1.5

1.4

524.00

375.14

mu/l

—

Pregnancy with abortive outcome

173

865

1.05

0.21

1.3

1.4

434.42

548.74

mu/l

1.67

162

823

Ulcerative rectosigmoiditis

104

0.77

0.21

1.3

1.4

352.50

428.80

mu/l

—

Iridocyclitis

258

1.12

0.21

1.3

1.4

538.51

428.33

mu/l

0.65

247

Intrahepatic Cholestasis of Pregnancy (ICP)

177

0.85

0.21

1.3

1.5

1456.67

436.41

mu/l

0.39

169

Persons with potential health hazards related to communicable diseases

108

1130

0.95

0.20

1.2

1.4

467.02

523.87

mu/l

0.33

100

1079

Disorders of synovium and tendon

781

1.06

0.20

1.4

715.31

854.56

mu/l

0.20

745

Dental pulpitis 2

118

573

1.05

0.20

1.3

1.5

386.19

589.12

mu/l

1.71

112

552

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

188

1229

1.04

0.19

1.3

1.5

781.56

694.38

mu/l

0.16

183

1164

182

1097

1.04

0.18

1.3

1.4

597.48

602.74

mu/l

0.02

168

1047

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

182

1097

1.04

0.18

1.3

1.4

597.48

602.74

mu/l

0.02

168

1047

Diabetic retinopathy, strict definition

209

0.88

0.18

1.4

1.3

411.19

1062.37

mu/l

0.73

195

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

120

0.86

0.18

1.2

1.4

330.00

834.52

mu/l

0.87

113

Diabetic nephropathy, excluding more controls

146

1.14

0.18

1.2

1.3

420.15

1188.78

mu/l

0.59

137

Pneumonia, organism unspecified

164

1142

1.04

0.17

1.3

1.4

607.75

726.64

mu/l

0.43

149

1083

Benign neoplasm: Skin of eyelid, including canthus

101

1.19

0.16

1.2

1.5

435.58

472.00

mu/l

0.10

Hernia

141

994

0.96

0.16

1.4

467.36

770.49

mu/l

1.46

133

944

Type 1 diabetes, strict (exclude DM2)

224

0.89

0.16

1.2

1.5

439.69

429.60

mu/l

0.05

211

Other/unspecified seropositive rheumatoid arthritis

193

0.88

0.15

1.4

1.5

551.18

443.27

mu/l

0.32

186

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

144

903

1.04

0.15

1.4

1.5

474.12

795.11

mu/l

1.46

136

856

Inflammatory bowel disease treatment related agents

242

1411

0.97

0.14

1.5

1.4

492.58

699.74

mu/l

1.30

237

1332

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

191

0.89

0.13

1.4

1.5

551.18

444.38

mu/l

0.31

184

Colorectal cancer

0.82

0.13

1.1

1.5

4197.75

399.11

mu/l

—

Fracture of forearm

789

1.04

0.13

1.4

1.5

765.91

449.79

mu/l

0.76

756

Other Crohn's disease

106

0.85

0.13

1.6

1.4

535.33

416.37

mu/l

—

101

Contraceptive management

650

1.04

0.11

1.3

1.5

392.67

575.36

mu/l

2.39

620

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

178

0.90

0.11

1.3

1.5

1370.69

436.69

mu/l

0.38

170

Cholelithiasis, broad definition with cholecystitis

123

816

1.03

0.11

1.6

1.5

532.32

759.16

mu/l

0.79

118

775

Scoliosis

188

0.90

0.11

1.2

1.4

461.06

477.77

mu/l

0.03

179

Injury, poisoning and certain other consequences of external causes

137

667

1.03

0.10

1.4

1.5

489.77

543.24

mu/l

0.27

132

638

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

0.87

0.10

1.5

1.4

9434.30

591.48

mu/l

—

Family history of malignant neoplasm

145

1.10

0.09

1.4

2579.38

414.66

mu/l

0.55

138

Sulfonylureas

124

0.90

0.09

1.1

1.4

330.07

1835.18

mu/l

0.95

115

Seropositive rheumatoid arthritis, wide

196

0.92

0.09

1.3

1.5

529.00

440.53

mu/l

0.26

189

Other heart diseases, wide

188

1142

1.02

0.08

1.4

516.37

645.24

mu/l

0.76

182

1080

Presence of cardiac and vascular implants and grafts

195

0.93

0.08

1.5

427.08

1509.50

mu/l

1.07

182

Dental caries 1, only avohilmo

132

658

1.03

0.08

1.3

1.5

396.90

567.35

mu/l

1.52

126

630

Methotrexate

146

1.10

0.08

2.0

1.4

486.50

437.41

mu/l

0.13

139

Type 1 diabetes, definitions combined

225

0.93

0.08

1.2

1.5

501.04

428.64

mu/l

0.34

212

Dental pulpitis 2, only avohilmo

117

584

1.03

0.07

1.3

1.5

383.21

586.09

mu/l

1.73

110

561

Other disorders of ear

131

853

1.02

0.07

1.4

1.5

412.28

768.47

mu/l

1.73

122

812

Asthma/COPD (KELA code 203)

203

1406

1.02

0.07

1.5

1.4

613.33

684.66

mu/l

0.27

196

1335

Bitten or struck by other mammals

196

1.07

0.07

1.2

1.4

520.64

393.45

mu/l

0.57

186

Crohn disease (strict definition, require KELA)

105

0.86

0.06

1.4

474.89

374.57

mu/l

—

100

All pneumoniae

195

1366

0.98

0.06

1.3

1.4

586.32

695.39

mu/l

0.48

180

1302

Hallux valgus (acquired)

206

0.95

0.06

2.0

1.5

831.48

551.33

mu/l

0.39

198

Other complications of labour and delivery, not elsewhere classified

508

0.97

0.06

1.3

1.5

289.47

510.69

mu/l

8.37

485

Insulin, fast-acting (human)

247

1.05

0.05

1.3

1.4

484.04

443.47

mu/l

0.13

234

Fracture of femur

118

1.08

0.05

1.9

1.4

374.53

430.93

mu/l

0.21

111

Pneumonias (Asthma/COPD co-morbidities)

193

1353

0.99

0.04

1.3

1.4

590.35

697.70

mu/l

0.46

178

1290

Dental caries 3, only avohilmo

144

747

0.99

0.04

1.3

1.4

402.88

552.88

mu/l

1.45

139

713

Dental caries, including avohilmo

126

634

1.02

0.04

1.3

1.5

411.69

573.52

mu/l

1.31

120

607

Dental caries 1

126

634

1.02

0.04

1.3

1.5

411.69

573.52

mu/l

1.31

120

607

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

160

0.94

0.04

1.3

1.4

1456.67

405.97

mu/l

0.40

153

Parodontitis or/and operation codes

121

730

0.99

0.04

1.4

534.20

783.61

mu/l

0.80

114

690

Congenital malformations and deformations of the musculoskeletal system

199

1.05

0.03

1.0

1.4

378.52

419.25

mu/l

0.22

191

Diseases of the respiratory system

143

708

1.01

0.03

1.3

1.5

397.52

619.61

mu/l

1.97

137

676

Influenza and pneumonia

218

1443

0.99

0.02

1.3

1.4

584.32

679.82

mu/l

0.43

203

1375

Fall on same level

260

1461

0.99

0.02

1.4

610.36

669.06

mu/l

0.18

248

1387

Injuries to the shoulder and upper arm

128

1063

1.01

0.02

1.5

1.4

987.87

680.88

mu/l

0.50

119

1008

Dental caries 3

143

725

1.01

0.01

1.3

1.4

413.88

556.21

mu/l

1.29

138

692

Deep endometriosis

137

0.95

0.01

1.1

1.5

208.15

434.39

mu/l

4.83

132

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

184

1300

0.99

0.01

1.3

1.5

590.21

709.87

mu/l

0.50

169

1238

Artrosis, including avohilmo

131

724

0.99

0.01

1.5

494.02

863.16

mu/l

1.27

125

689

Other maternal disorders predominantly related to pregnancy

151

944

1.01

0.01

1.3

1.4

438.18

550.46

mu/l

1.50

144

894

Tooth eruption problems

541

0.99

0.00

1.4

450.33

497.44

mu/l

0.31

510

Artificial joint operation, meniscal resection

638

1.00

0.00

1.5

526.67

858.53

mu/l

0.91

608

Special screening examination for other diseases and disorders

125

0.96

0.00

1.7

1.4

784.67

364.48

mu/l

1.43

119

Peritonsillar abscess

455

0.99

0.00

1.2

1.4

492.56

523.53

mu/l

0.12

437

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

114

0.96

0.00

1.4

1.5

412.73

400.51

mu/l

0.03

109

Aortic aneurysm

114

1.03

0.00

1.1

1.4

268.50

555.27

mu/l

0.82

109

Failed induction of labour

213

0.99

0.00

1.2

1.5

329.62

438.47

mu/l

1.43

200

Seropositive rheumatoid arthritis

184

0.98

0.00

1.3

1.5

529.00

418.31

mu/l

0.35

177

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

163

0.98

0.00

1.3

1.4

1370.69

404.38

mu/l

0.39

156

Use of galantamine

0.00

0.0

1.6

—

327.00

—

Malignant neoplasm of bone and articular cartilage of limbs

0.00

0.0

1.3

—

395.33

—

Isolated patent ductus arteriosus

0.00

0.0

1.5

—

339.50

—

Other congenital musculoskeletal deformities

0.00

0.0

1.4

—

423.20

—

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

1.01

0.00

1.2

1.3

292.83

765.33

mu/l

—

Squamous cell neoplasms and carcinoma of cervix, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

409.80

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

0.0

1.4

—

259.20

—

Other autoimmune haemolytic anaemias

0.00

0.0

1.6

—

559.40

—

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

0.92

0.00

1.1

1.5

278.88

682.05

mu/l

—

Mucinous and mucinous cystic tumor, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.4

—

454.20

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

160

1.00

0.00

2.1

1.6

453.81

423.93

mu/l

0.11

154

Oral lichen ruber planus, hypothyreosis or thyroxin

0.00

0.0

1.2

—

447.50

—

Female infertility, uterine origin

0.00

0.0

1.7

—

481.33

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

0.0

1.0

—

435.50

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Prolactin monomeric [Units/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS